Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,053

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

Open access
Vince, James E., Wong, W. Wei-Lynn, Khan, Nufail, Feltham, Rebecca, Chau, Diep, Ahmed, Afsar U., Benetatos, Christopher A., Chunduru, Srinivas K., Condon, Stephen M., McKinlay, Mark, Brink, Robert, Leverkus, Martin, Tergaonkar, Vinay, Schneider, Pascal, Callus, Bernard A., Koentgen, Frank, Vaux, David L., Silke, John·2007·Cell
DOI 10.1016/j.cell.2007.10.037
Open this paper in CoChat — free account

Abstract

XIAP prevents apoptosis by binding to and inhibiting caspases, and this inhibition can be relieved by IAP antagonists, such as Smac/DIABLO. IAP antagonist compounds (IACs) have therefore been designed to inhibit XIAP to kill tumor cells. Because XIAP inhibits postmitochondrial caspases, caspase 8 inhibitors should not block killing by IACs. Instead, we show that apoptosis caused by an IAC is blocked by the caspase 8 inhibitor crmA and that IAP antagonists activate NF-kappaB signaling via inhibtion of cIAP1. In sensitive tumor lines, IAP antagonist induced NF-kappaB-stimulated production of TNFalpha that killed cells in an autocrine fashion. Inhibition of NF-kappaB reduced TNFalpha production, and blocking NF-kappaB activation or TNFalpha allowed tumor cells to survive IAC-induced apoptosis. Cells treated with an IAC, or those in which cIAP1 was deleted, became sensitive to apoptosis induced by exogenous TNFalpha, suggesting novel uses of these compounds in treating cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2007.10.037

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 32

  1. Bossen, 2006, Interactions of TNF and TNF receptor family members in the mouse and human, J. Biol. Chem., 281, 13964, 10.1074/jbc.M601553200 · DOI · Paper page
  2. Broemer, 2004, Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation, Oncogene, 23, 5378, 10.1038/sj.onc.1207705 · DOI
  3. Chai, 2000, Structural and biochemical basis of apoptotic activation by Smac/DIABLO, Nature, 406, 855, 10.1038/35022514 · DOI · Paper page
  4. Chen, 2002, TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90, Mol. Cell, 9, 401, 10.1016/S1097-2765(02)00450-1 · DOI · Paper page
  5. Conte, 2006, Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival, Mol. Cell. Biol., 26, 699, 10.1128/MCB.26.2.699-708.2006 · DOI
  6. Conze, 2005, Posttranscriptional Downregulation of c-IAP2 by the Ubiquitin Protein Ligase c-IAP1 In Vivo, Mol. Cell. Biol., 25, 3348, 10.1128/MCB.25.8.3348-3356.2005 · DOI
  7. Creagh, 2004, Smac/Diablo antagonizes ubiquitin ligase activity of IAPs, J. Biol. Chem., 279, 26906, 10.1074/jbc.M313859200 · DOI
  8. Dejardin, 2002, The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways, Immunity, 17, 525, 10.1016/S1074-7613(02)00423-5 · DOI · Paper page
  9. Fotin-Mleczek, 2002, Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8, J. Cell Sci., 115, 2757, 10.1242/jcs.115.13.2757 · DOI · Paper page
  10. Grech, 2004, TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells, Immunity, 21, 629, 10.1016/j.immuni.2004.09.011 · DOI
  11. Harlin, 2001, Characterization of XIAP-deficient mice, Mol. Cell. Biol., 21, 3604, 10.1128/MCB.21.10.3604-3608.2001 · DOI · Paper page
  12. He, 2006, Rescue of TRAF3-null mice by p100 NF-κB deficiency, J. Exp. Med., 203, 2413, 10.1084/jem.20061166 · DOI
  13. Li, 2004, A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death, Science, 305, 1471, 10.1126/science.1098231 · DOI · Paper page
  14. Li, 2002, TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2, Nature, 416, 345, 10.1038/416345a · DOI · Paper page
  15. Nikolovska-Coleska, 2004, Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization, Anal. Biochem., 332, 261, 10.1016/j.ab.2004.05.055 · DOI · Paper page
  16. Nowakowski, 2006, A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer, Clin. Cancer Res., 12, 6087, 10.1158/1078-0432.CCR-06-1015 · DOI
  17. Oost, 2004, Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer, J. Med. Chem., 47, 4417, 10.1021/jm040037k · DOI · Paper page
  18. Rothe, 1995, The TNF-R2-TRAF signaling complex contains two novel proteins related to baculoviral-inhibitor of apoptosis proteins, Cell, 83, 1243, 10.1016/0092-8674(95)90149-3 · DOI · Paper page
  19. Samuel, 2006, Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of TRAF2 and Smac, J. Biol. Chem., 281, 1080, 10.1074/jbc.M509381200 · DOI
  20. Schimmer, 2004, Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity, Cancer Cell, 5, 25, 10.1016/S1535-6108(03)00332-5 · DOI · Paper page
  21. Senftleben, 2001, Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway, Science, 293, 1495, 10.1126/science.1062677 · DOI · Paper page
  22. Shu, 1996, The TNF-R2 signal transducers TRAF2 and c-IAP1 are components of the TNF-R1 signaling complex, Proc. Natl. Acad. Sci. USA, 93, 13973, 10.1073/pnas.93.24.13973 · DOI · Paper page
  23. Silke, 2004, Unlike DIABLO/Smac, Grim promotes global ubiquitination and specific degradation of XIAP and neither cause apoptosis, J. Biol. Chem., 279, 4313, 10.1074/jbc.M305661200 · DOI
  24. Srinivasula, 2001, A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis, Nature, 410, 112, 10.1038/35065125 · DOI · Paper page
  25. Tenev, 2005, IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms, Nat. Cell Biol., 7, 70, 10.1038/ncb1204 · DOI
  26. Uren, 1996, Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors, Proc. Natl. Acad. Sci. USA, 93, 4974, 10.1073/pnas.93.10.4974 · DOI · Paper page
  27. Van Antwerp, 1996, Suppression of TNFα-induced apoptosis by NF-κB, Science, 274, 787, 10.1126/science.274.5288.787 · DOI · Paper page
  28. Varfolomeev, 2006, The inhibitor of apoptosis protein fusion c-IAP2/MALT1 stimulates NF-κB activation independently of TRAF1 and TRAF2, J. Biol. Chem., 281, 29022, 10.1074/jbc.M605116200 · DOI
  29. Wang, 2006, 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway, Cancer Res., 66, 1089, 10.1158/0008-5472.CAN-05-2698 · DOI
  30. Werner, 2005, Stimulus specificity of gene expression programs determined by temporal control of IKK activity, Science, 309, 1857, 10.1126/science.1113319 · DOI · Paper page
  31. Yang, 2004, Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells, J. Biol. Chem., 279, 16963, 10.1074/jbc.M401253200 · DOI
  32. Zender, 2006, Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach, Cell, 125, 1253, 10.1016/j.cell.2006.05.030 · DOI · Paper page

Cited by

See all 1,053

Metadata

Authors
Vince, J. E., Wong, W. W.-L., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M., Brink, R., Leverkus, M., Tergaonkar, V., Schneider, P., Callus, B. A., Koentgen, F., Vaux, D. L., & Silke, J.
Venue
Cell
Publisher
Elsevier BV
Published
2007-11
Volume
131
Issue
4
Pages
682-693
ISSN
0092-8674 (ISSN-L)
DOI
10.1016/j.cell.2007.10.037
OpenAlex
W2069800916
Cited by
1,053
References
3
FWCI
27.66
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.